Share Name Share Symbol Market Type Share ISIN Share Description
Circassia Pharmaceuticals Plc LSE:CIR London Ordinary Share GB00BJVD3B28 ORD 0.08P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.60 3.64% 17.10 17.05 17.20 17.20 16.30 16.60 2,338,018 16:35:25
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 48.3 -55.8 -34.0 - 64

Circassia Pharmaceuticals Plc Holding(s) in Company

19/09/2019 5:40pm

UK Regulatory (RNS & others)


TIDMCIR

RNS Number : 0314N

Circassia Pharmaceuticals Plc

19 September 2019

TR-1: Standard form for notification of major holdings

 
 NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and 
  to the FCA in Microsoft Word format if possible)(i) 
 
 1a. Identity of the issuer or the                                           CIRCASSIA PHARMACEUTICALS PLC 
  underlying issuer of existing shares 
  to which voting rights are attached(ii) 
  : 
                                                             --------------------------------------------- 
 1b. Please indicate if the issuer is a non-UK issuer (please mark with 
  an "X" if appropriate) 
 Non-UK issuer 
                                                                                                      ---- 
 2. Reason for the notification (please mark the appropriate box or boxes 
  with an "X") 
 An acquisition or disposal of voting rights                                                            X 
                                                                                                      ---- 
 An acquisition or disposal of financial instruments 
                                                                                                      ---- 
 An event changing the breakdown of voting rights 
                                                                                                      ---- 
 Other (please specify)(iii) : 
                                                                                                      ---- 
 3. Details of person subject to the notification obligation(iv) 
 Name                                                         Société Générale 
                                                               SA (SG SA) 
 City and country of registered office                        Puteaux, France 
  (if applicable) 
 4. Full name of shareholder(s) (if different from 3.)(v) 
 Name 
                                                             --------------------------------------------- 
 City and country of registered office 
  (if applicable) 
                                                             --------------------------------------------- 
 5. Date on which the threshold was                           18/09/2019 
  crossed or reached(vi) : 
                                                             --------------------------------------------- 
 6. Date on which issuer notified (DD/MM/YYYY):               19/09/2019 
                                                             --------------------------------------------- 
 7. Total positions of person(s) subject to the notification obligation 
                              % of voting       % of voting rights     Total of both   Total number 
                            rights attached      through financial      in % (8.A +     of voting rights 
                            to shares (total        instruments             8.B)        of issuer(vii) 
                                of 8. A)           (total of 8.B 
                                                     1 + 8.B 2) 
                          ------------------  ----------------------  --------------  -------------------- 
 Resulting situation 
  on the date 
  on which threshold 
  was crossed 
  or reached                     5.99%                 0.02%               6.01%           375,178,308 
                          ------------------  ----------------------  --------------  -------------------- 
 Position of 
  previous notification 
  (if 
  applicable)                   13.74%                 0.00%              13.74% 
                          ------------------  ----------------------  --------------  -------------------- 
 
 
 
 8. Notified details of the resulting situation on the date on which the 
  threshold was crossed or reached(viii) 
 A: Voting rights attached to shares 
 Class/type of      Number of voting rights(ix)                             % of voting rights 
  shares 
  ISIN code (if 
  possible) 
                            Direct                     Indirect                      Direct                  Indirect 
                      (Art 9 of Directive         (Art 10 of Directive         (Art 9 of Directive     (Art 10 of Directive 
                          2004/109/EC)                2004/109/EC)            2004/109/EC) (DTR5.1)        2004/109/EC) 
                            (DTR5.1)                   (DTR5.2.1)                                           (DTR5.2.1) 
                                             ---------------------------- 
 GB00BJVD3B28 
  Ordinary shares         22,446,654                       0                         5.99%                      0% 
                   ------------------------  ----------------------------  -------------------------  --------------------- 
 GB00BJVD3B28 
  Borrowed 
  Ordinary 
  shares                       0                           0                           0%                       0% 
                   ------------------------  ----------------------------  -------------------------  --------------------- 
 SUBTOTAL 8. A                           22,446,654                                              5.99% 
                   ------------------------------------------------------  ------------------------------------------------ 
 
 B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC 
  (DTR5.3.1.1 (a)) 
 Type of            Expiration   Exercise/                           Number of voting                  % of voting 
 financial           date(x)      Conversion Period(xi)               rights that may                   rights 
 instrument                                                           be acquired if 
                                                                      the instrument 
                                                                      is 
                                                                      exercised/converted. 
                   -----------  ----------------------------------  --------------------------------  --------------------- 
 
 
 
                                 SUBTOTAL 8. B 1 
                                ----------------------------------  --------------------------------  --------------------- 
 
 B 2: Financial Instruments with similar economic effect according to 
  Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b)) 
 Type of        Expiration       Exercise/               Physical or             Number of             % of voting 
 financial       date(x)          Conversion              cash                    voting rights         rights 
 instrument                       Period (xi)             settlement 
               ---------------  ----------------------  ----------------------  -------------------- 
 Dynamic 
  Portfolio 
  Swaps Buy           N/A                  N/A              Cash settlement            85,000                  0.02% 
               ---------------  ----------------------  ----------------------  -------------------- 
 
 
                                                         SUBTOTAL 8.B.2                85,000                 0.02% 
                                                        ----------------------  -------------------- 
 
 
 
 
 9. Information in relation to the person subject to the notification 
  obligation (please mark the 
  applicable box with an "X") 
 Person subject to the notification obligation is not controlled                        X 
  by any natural person or legal entity and does not control any other 
  undertaking(s) holding directly or indirectly an interest in the 
  (underlying) issuer(xiii) 
 Full chain of controlled undertakings through which the voting rights 
  and/or the 
  financial instruments are effectively held starting with the ultimate 
  controlling natural person or legal entity(xiv) (please add additional 
  rows as necessary) 
     Name(xv)        % of voting rights      % of voting rights       Total of both if 
                       if it equals or        through financial        it equals or is 
                      is higher than the      instruments if it        higher than the 
                     notifiable threshold    equals or is higher     notifiable threshold 
                                             than the notifiable 
                                                  threshold 
                   ----------------------  ---------------------  ------------------------ 
 
 
 
 
 
 
 10. In case of proxy voting, please identify: 
 Name of the proxy holder 
                                           ----------------------------------------------- 
 The number and % of voting rights 
  held 
                                           ----------------------------------------------- 
 The date until which the voting rights 
  will be held 
                                           ----------------------------------------------- 
 
 11. Additional information(xvi) 
 
 
 
 
 Place of completion   Oxford, UK 
 Date of completion    September 19(th) , 2019 
                      ------------------------ 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

HOLUKONRKBAKAAR

(END) Dow Jones Newswires

September 19, 2019 12:40 ET (16:40 GMT)

1 Year Circassia Pharmaceuticals Chart

1 Year Circassia Pharmaceuticals Chart

1 Month Circassia Pharmaceuticals Chart

1 Month Circassia Pharmaceuticals Chart
Your Recent History
LSE
CIR
Circassia ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20191121 00:47:58